These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19862729)

  • 1. [Successful concept: proteases as targets for anti-infectives. New targets in the treatment of infection].
    Schirmeister T; Welker A
    Pharm Unserer Zeit; 2009; 38(6):564-74; quiz 576-7. PubMed ID: 19862729
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug discovery and the use of computational approaches for infectious diseases.
    Marhöfer RJ; Oellien F; Selzer PM
    Future Med Chem; 2011 Jun; 3(8):1011-25. PubMed ID: 21707402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic protease inhibitors as novel therapeutic agents.
    Scott CJ; Taggart CC
    Biochimie; 2010 Nov; 92(11):1681-8. PubMed ID: 20346385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations.
    Rich DH; Bursavich MG; Estiarte MA
    Biopolymers; 2002; 66(2):115-25. PubMed ID: 12325161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasite proteases and antimalarial activities of protease inhibitors.
    Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
    Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecule of the month. LBM-415.
    Drug News Perspect; 2005; 18(1):46. PubMed ID: 15753974
    [No Abstract]   [Full Text] [Related]  

  • 8. SAR analysis and bioactive potentials of freshwater and terrestrial cyanobacterial compounds: a review.
    Nagarajan M; Maruthanayagam V; Sundararaman M
    J Appl Toxicol; 2013 May; 33(5):313-49. PubMed ID: 23172644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interview with Lorenz M. Mayr, Ph.D.
    Mayr LM
    Assay Drug Dev Technol; 2009 Oct; 7(5):419-23. PubMed ID: 19895347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiinfective, antitoxic and antiparasitic effects of exogenic DNA].
    Besednova NN; Zaporozhets TS
    Antibiot Khimioter; 2010; 55(7-8):46-55. PubMed ID: 21140565
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteolytic inhibitors: implications on microorganisms development, virulence and pathogenesis.
    dos Santos AL; Sodré CL; Branquinha MH; d'Avila-Levy CM
    Curr Med Chem; 2013; 20(25):3035-40. PubMed ID: 23848538
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
    Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
    J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The situation on antimicrobial agents and chemotherapy in 2002: highlights of the 42nd ICAAC.
    Giglione C; Meinnel T
    Expert Opin Ther Targets; 2002 Dec; 6(6):691-7. PubMed ID: 12472381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and challenges in anti-infective research and development: new drugs and approaches.
    Labischinski H; Ruebsamen-Waigmann H
    Curr Opin Pharmacol; 2008 Oct; 8(5):519-21. PubMed ID: 18848903
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovering new antimicrobial agents.
    Moellering RC
    Int J Antimicrob Agents; 2011 Jan; 37(1):2-9. PubMed ID: 21075608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Development of New Anti-infectives: Perspectives and Prospective.
    Kothari V
    Curr Drug Discov Technol; 2020; 17(4):414. PubMed ID: 32907529
    [No Abstract]   [Full Text] [Related]  

  • 17. The search for new anti-infective drugs: untapped resources and strategies.
    Bierbaum G; Sahl HG
    Int J Med Microbiol; 2014 Jan; 304(1):1-2. PubMed ID: 24183099
    [No Abstract]   [Full Text] [Related]  

  • 18. Parasite chemotherapy.
    Thompson PE
    Annu Rev Pharmacol; 1967; 7():77-100. PubMed ID: 4953087
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.
    Song R; Qiao W; He J; Huang J; Luo Y; Yang T
    J Med Chem; 2021 Mar; 64(6):2851-2877. PubMed ID: 33656892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
    Abdel-Rahman HM; Kimura T; Hidaka K; Kiso A; Nezami A; Freire E; Hayashi Y; Kiso Y
    Biol Chem; 2004 Nov; 385(11):1035-9. PubMed ID: 15576323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.